Oncogenic transcription factor Evi1 regulates hematopoietic stem cell proliferation through GATA‐2 expression
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
‘Green mice’ as a source of ubiquitous green cells
Okabe, M., Ikawa, M., Kominami, K., Nakanishi, T., & Nishimune, Y. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00313-x · Cited by 2,581 · cited 1×
“To test the hypothesis that hematopoietic cells could promote angiogenesis in Evi1 / P-Sp cultures, HSCs from the adult bone marrow of transgenic mice harboring green fluorescent protein (GFP) (Okabe et al, 1997) were sorted by flow cytometry and then added to a P-Sp culture of Evi1 / embryos.”
MethodOkuda, T., van Deursen, J., Hiebert, S. W., Grosveld, G., & Downing, J. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80986-1 · Cited by 1,856
Definitive Hematopoiesis Is Autonomously Initiated by the AGM Region
Medvinsky, A., & Dzierzak, E. (1996) · Cell · doi:10.1016/s0092-8674(00)80165-8 · Cited by 1,548 · cited 2×
“Using an irradiated adult mouse as a recipient, the definitive HSC activity was first detectable in the Aorta-Gonad-Mesonephros (AGM) region of the embryo at day 10.5 by the transplantation of donor test cells with competitor cells (Medvinsky and Dzierzak, 1996).”
BackgroundInfluentialAn early haematopoietic defect in mice lacking the transcription factor GATA-2
Tsai, F.-Y., Keller, G., Kuo, F. C., Weiss, M., Chen, J., Rosenblatt, M., Alt, F. W., & Orkin, S. H. (1994) · Nature · doi:10.1038/371221a0 · Cited by 1,237 · cited 3×
“In GATA-2 homozygous mutant mice, severe defects in both the yolk sac and definitive hematopoi- esis were seen (Tsai et al, 1994).”
BackgroundA functional c-myb gene is required for normal murine fetal hepatic hematopoiesis
Mucenski, M. L., McLain, K., Kier, A. B., Swerdlow, S. H., Schreiner, C. M., Miller, T. A., Pietryga, D. W., Scott, W. J., & Potter, S. S. (1991) · Cell · doi:10.1016/0092-8674(91)90099-k · Cited by 1,042 · cited 1×
“These mice show embryonic lethality at midgestation with severe hemorrhaging and/or defects in vascular development (Mucenski et al, 1991; Okuda et al, 1996; Visvader et al, 1998).”
BackgroundSelf-citationIscove, N. N., Sieber, F., & Winterhalter, K. H. (1974) · Journal of Cellular Physiology · doi:10.1002/jcp.1040830218 · Cited by 822 · cited 1×
“…the differentiation capacity of the Evi1-deficient hematopoietic cells, hemato- poietic cells derived from P-Sp explants were subjected to in vitro colony assays in a semisolid agar culture (Iscove et al, 1974) supplemented with stem cell factor (SCF), interleukin 3 (IL-3) and erythropoietin (Epo).”
MethodHEL Cells: A New Human Erythroleukemia Cell Line with Spontaneous and Induced Globin Expression
Martin, P., & Papayannopoulou, T. (1982) · Science · doi:10.1126/science.6177045 · Cited by 617 · cited 2×
“Each reporter plasmid was transiently transfected into EML C1, a murine stem cell factor-dependent multipotent progenitor cell line (Tsai et al, 1994), or HEL, a human erythroleukemia cell line (Martin and Papayannopoulou, 1982).”
BackgroundA Role for Hematopoietic Stem Cells in Promoting Angiogenesis
Takakura, N., Watanabe, T., Suenobu, S., Yamada, Y., Noda, T., Ito, Y., Satake, M., & Suda, T. (2000) · Cell · doi:10.1016/s0092-8674(00)00025-8 · Cited by 506 · cited 18×
“We finally observed that the forced expression of Evi1 induced GATA-2 expression in a hemato- poietic cell line, EML C1, along with GATA-1, Ang-1, Ang-2 and Tie2 at 2 months after transfection (Supplementary Figure 6B).”
BackgroundMethodInfluentialSelf-citationCharacterization of Definitive Lymphohematopoietic Stem Cells in the Day 9 Murine Yolk Sac
Yoder, M. C., Hiatt, K., Dutt, P., Mukherjee, P., Bodine, D. M., & Orlic, D. (1997) · Immunity · doi:10.1016/s1074-7613(00)80355-6 · Cited by 419 · cited 2×
“5 P-Sp region into the livers of sublethally conditioned newborn mice, and this strategy has been reported to detect the HSC activity as early as on day 8 or 9 in both yolk sac and P-Sp (Yoder et al, 1997).”
BackgroundMethodThe Genetic Program of Hematopoietic Stem Cells
Phillips, R. L., Ernst, R. E., Brunk, B., Ivanova, N., Mahan, M. A., Deanehan, J. K., Moore, K. A., Overton, G. C., & Lemischka, I. R. (2000) · Science · doi:10.1126/science.288.5471.1635 · Cited by 413 · cited 1×
“Moreover, Evi1 has been shown to be expressed in bone marrow hematopoietic stem cells (HSCs), implying that Evi1 plays a role in the regulation of HSCs (Phillips et al, 2000; Park et al, 2002; Shimizu et al, 2002).”
BackgroundMorishita, K., Parker, D. S., Mucenski, M. L., Jenkins, N. A., Copeland, N. G., & Ihle, J. N. (1988) · Cell · doi:10.1016/s0092-8674(88)91175-0 · Cited by 404 · cited 1×
“The ecotropic viral integration site-1 (Evi1) was first identified as a common site of retroviral integration in murine myeloid tumors (Morishita et al, 1988; Mucenski et al, 1988).”
BackgroundSelf-citationUse of Chromatin Immunoprecipitation To Clone Novel E2F Target Promoters
Weinmann, A. S., Bartley, S. M., Zhang, T., Zhang, M. Q., & Farnham, P. J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.20.6820-6832.2001 · Cited by 384 · cited 1×
“A ChIP analysis was performed as described previously (Weinmann et al, 2001).”
MethodThe oncoprotein Evi-1 represses TGF-β signalling by inhibiting Smad3
Kurokawa, M., Mitani, K., Irie, K., Matsuyama, T., Takahashi, T., Chiba, S., Yazaki, Y., Matsumoto, K., & Hirai, H. (1998) · Nature · doi:10.1038/27945 · Cited by 371 · cited 1×
“…2005 1985 Several underlying molecular mechanisms of Evi1 expres- sion have been proposed, including an enhanced AP-1 activity (Tanaka et al, 1994), the antagonizing growth- inhibitory effects of TGFb (Kurokawa et al, 1998) and a differentiation block (Morishita et al, 1992a; Kreider et al, 1993).”
BackgroundGodin, I., Dieterlen-Lièvre, F., & Cumano, A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.3.773 · Cited by 350 · cited 1×
“In addition, we found an abundant Evi1 expression in both the yolk sac and para-aortic splanch- no-pleural (P-Sp) region, where primitive (embryo-type) and definitive (adult-type) hematopoiesis occurs, respectively (Godin et al, 1995).”
BackgroundUnsuspected role for the T-cell leukemia protein SCL/tal-1 in vascular development
Visvader, J. E., Fujiwara, Y., & Orkin, S. H. (1998) · Genes & Development · doi:10.1101/gad.12.4.473 · Cited by 328 · cited 1×
“These mice show embryonic lethality at midgestation with severe hemorrhaging and/or defects in vascular development (Mucenski et al, 1991; Okuda et al, 1996; Visvader et al, 1998).”
BackgroundMitani, K., Ogawa, S., Tanaka, T., Miyoshi, H., Kurokawa, M., Mano, H., Yazaki, Y., Ohki, M., & Hirai, H. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06288.x · Cited by 325 · cited 1×
“Rearrangements involving human Evi1 on chro- mosome 3q26 often activate its expression in human acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) (Morishita et al, 1992b; Mitani et al, 1994).”
BackgroundCritical Role of the TIE2 Endothelial Cell Receptor in the Development of Definitive Hematopoiesis
Takakura, N., Huang, X.-L., Naruse, T., Hamaguchi, I., Dumont, D. J., Yancopoulos, G. D., & Suda, T. (1998) · Immunity · doi:10.1016/s1074-7613(00)80665-2 · Cited by 302 · cited 2×
“Production of recombinant Tie2-Fc and CD4-Fc fusion protein Recombinant fusion proteins of the extracellular domain of murine surface molecules (Tie2 or CD4) and the Fc part of human Ig were designed (Tie2-Fc or CD4-Fc) as described previously (Takakura et al, 1998).”
MethodSelf-citationMorishita, K., Parganas, E., William, C. L., Whittaker, M. H., Drabkin, H., Oval, J., Taetle, R., Valentine, M. B., & Ihle, J. N. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.9.3937 · Cited by 276 · cited 2×
“…2005 1985 Several underlying molecular mechanisms of Evi1 expres- sion have been proposed, including an enhanced AP-1 activity (Tanaka et al, 1994), the antagonizing growth- inhibitory effects of TGFb (Kurokawa et al, 1998) and a differentiation block (Morishita et al, 1992a; Kreider et al, 1993).”
BackgroundSelf-citationMucenski, M. L., Taylor, B. A., Ihle, J. N., Hartley, J. W., Morse, H. C., Jenkins, N. A., & Copeland, N. G. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.1.301 · Cited by 199
Self-citationOike, Y., Takakura, N., Hata, A., Kaname, T., Akizuki, M., Yamaguchi, Y., Yasue, H., Araki, K., Yamamura, K.-I., & Suda, T. (1999) · Blood · doi:10.1182/blood.v93.9.2771 · Cited by 184
Self-citationDifferential gene expression profiling of adult murine hematopoietic stem cells
Park, I.-K., He, Y., Lin, F., Laerum, O. D., Tian, Q., Bumgarner, R., Klug, C. A., Li, K., Kuhr, C., Doyle, M. J., et al. (2002) · Blood · doi:10.1182/blood.v99.2.488 · Cited by 168 · cited 1×
“Moreover, Evi1 has been shown to be expressed in bone marrow hematopoietic stem cells (HSCs), implying that Evi1 plays a role in the regulation of HSCs (Phillips et al, 2000; Park et al, 2002; Shimizu et al, 2002).”
BackgroundHoyt, P. R., Bartholomew, C., Davis, A. J., Yutzey, K., Gamer, L. W., Potter, S. S., Ihle, J. N., & Mucenski, M. L. (1997) · Mechanisms of Development · doi:10.1016/s0925-4773(97)00057-9 · Cited by 164 · cited 2×
“Evi1 mutant mice (Hoyt et al, 1997) and 7.0IS-GFP transgenic mice (Minegishi et al, 1999) were used in this study.”
BackgroundMethodSelf-citationRequirement for the TIE family of receptor tyrosine kinases in adult but not fetal hematopoiesis
Puri, M. C., & Bernstein, A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2133552100 · Cited by 136 · cited 2×
“is not required for the differentiation and proliferation of embryonic and fetal hematopoiesis (Puri and Bernstein, 2003).”
BackgroundKreider, B. L., Orkin, S. H., & Ihle, J. N. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6454 · Cited by 129 · cited 1×
“…2005 1985 Several underlying molecular mechanisms of Evi1 expres- sion have been proposed, including an enhanced AP-1 activity (Tanaka et al, 1994), the antagonizing growth- inhibitory effects of TGFb (Kurokawa et al, 1998) and a differentiation block (Morishita et al, 1992a; Kreider et al, 1993).”
BackgroundAlternative Promoters Regulate Transcription of the Mouse GATA-2 Gene
Minegishi, N., Ohta, J., Suwabe, N., Nakauchi, H., Ishihara, H., Hayashi, N., & Yamamoto, M. P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3625 · Cited by 120 · cited 2×
“The distal IS exon is specifically used in hematopoietic and neural cells, whereas the proximal IG exon is used in a variety of cells (Minegishi et al, 1998).”
BackgroundInfluentialMinegishi, N., Suzuki, N., Yokomizo, T., Pan, X., Fujimoto, T., Takahashi, S., Hara, T., Miyajima, A., Nishikawa, S.-I., & Yamamoto, M. P. (2003) · Blood · doi:10.1182/blood-2002-12-3809 · Cited by 118 · cited 1×
“Since GATA-2 strongly blocks hematopoietic cell differ- entiation and stimulates immature cell proliferation (Minegishi et al, 2003), it is possible that the ectopic expres- sion of Evi1 induces an aberrant GATA-2 expression, which is in some part responsible for the oncogenic activity of Evi1.”
BackgroundMorishita, K., Parganas, E., Matsugi, T., & Ihle, J. N. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.1.183-189.1992 · Cited by 116 · cited 2×
“…2005 1985 Several underlying molecular mechanisms of Evi1 expres- sion have been proposed, including an enhanced AP-1 activity (Tanaka et al, 1994), the antagonizing growth- inhibitory effects of TGFb (Kurokawa et al, 1998) and a differentiation block (Morishita et al, 1992a; Kreider et al, 1993).”
BackgroundSelf-citationMinegishi, N., Ohta, J., Yamagiwa, H., Suzuki, N., Kawauchi, S., Zhou, Y., Takahashi, S., Hayashi, N., Engel, J. D., & Yamamoto, M. (1999) · Blood · doi:10.1182/blood.v93.12.4196 · Cited by 111
Perkins, A. S., Mercer, J. A., Jenkins, N. A., & Copeland, N. G. (1991) · Development · doi:10.1242/dev.111.2.479 · Cited by 104
Self-citationTanaka, T., Nishida, J., Mitani, K., Ogawa, S., Yazaki, Y., & Hirai, H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)51041-9 · Cited by 94 · cited 1×
“…VOL 24 | NO 11 | 2005 1985 Several underlying molecular mechanisms of Evi1 expres- sion have been proposed, including an enhanced AP-1 activity (Tanaka et al, 1994), the antagonizing growth- inhibitory effects of TGFb (Kurokawa et al, 1998) and a differentiation block (Morishita et al,…”
BackgroundMatsugi, T., Morishita, K., & Ihle, J. N. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.3.1259-1264.1990 · Cited by 70
Self-citationMorishita, K., Suzukawa, K., Taki, T., Ihle, J. N., & Yokota, J. (1995) · PubMed · Cited by 51
Self-citationKaneko, S., Onodera, M., Fujiki, Y., Nagasawa, T., & Nakauchi, H. (2001) · Human Gene Therapy · doi:10.1089/104303401450942 · Cited by 39 · cited 2×
“P-Sp explants alone were infected with either an Evi1 retrovirus (Evi1-IRES-EGFP) or a mock EGFP retrovirus (EGFP) as a control (Kaneko et al, 2001) and were then collected for a quantitative RT–PCR analysis on day 4.”
MethodShimizu, S., Nagasawa, T., Katoh, O., Komatsu, N., Yokota, J., & Morishita, K. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6693 · Cited by 37 · cited 1×
“Moreover, Evi1 has been shown to be expressed in bone marrow hematopoietic stem cells (HSCs), implying that Evi1 plays a role in the regulation of HSCs (Phillips et al, 2000; Park et al, 2002; Shimizu et al, 2002).”
BackgroundSelf-citation
Cited by
Seven sirtuins for seven deadly diseases ofaging
Morris, B. J. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.10.525 · Cited by 377
Evi-1 Is a Critical Regulator for Hematopoietic Stem Cells and Transformed Leukemic Cells
Goyama, S., Yamamoto, G., Shimabe, M., Sato, T., Ichikawa, M., Ogawa, S., Chiba, S., & Kurokawa, M. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.06.002 · Cited by 287
PRDM proteins: important players in differentiation and disease
Fog, C. K., Galli, G. G., & Lund, A. H. (2012) · BioEssays · doi:10.1002/bies.201100107 · Cited by 201
“Prdm3/Evi1 deficient HSCs from fetal liver lost their reconstitution capability, which appeared to involve lack of Prdm3/ Evi1-mediated transcriptional activation of Gata2 [44, 46] and a decrease of the HSC pool was also found upon inducible loss of Prdm3/Evi1 in adult mice [44].”
BackgroundShen, C., Chen, M.-T., Zhang, X.-H., Yin, X.-L., Ning, H.-M., Su, R., Lin, H.-S., Song, L., Wang, F., Ma, Y.-N., et al. (2016) · PLOS Genetics · doi:10.1371/journal.pgen.1006259 · Cited by 62
“Interestingly, MECOM was reported to directly target the GATA2 promoter to promote its transcription [25].”
BackgroundRetracted
Metadata
- Authors
- Yuasa, H., Oike, Y., Iwama, A., Nishikata, I., Sugiyama, D., Perkins, A., Mucenski, M. L., Suda, T., & Morishita, K.
- Venue
- The EMBO Journal
- Published
- 2005-05-12
- Volume
- 24
- Issue
- 11
- Pages
- 1976-1987
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- OpenAlex
- W2071831776
- Cited by
- 213
- References
- 34
- FWCI
- 6.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.